ReviewCurrent opinion in microbiology2026
Current perspectives of host-pathogen dynamics in coccidioidomycosis.
Review in Current opinion in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Coccidioidomycosis (CM), commonly known as Valley fever, is a respiratory infection caused by the inhalation or implantation of infectious arthroconidia produced by the dimorphic human fungal pathogens Coccidioides immitis and Coccidioides posadasii from the environment. The current endemic range includes the southwestern region of the United States and parts of South and Central America. Infected individuals may experience a spectrum of symptoms from asymptomatic to severe respiratory symptoms. Importantly, the fungus can disseminate to other tissues to produce severe symptoms, and in some cases, death. Despite significant effort from Coccidioides researchers to develop effective vaccines against Valley fever, there is currently no human vaccine available. This review highlights the recent advances in understanding host immune response and addressing knowledge gaps in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.